Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural basis for broad coronavirus neutralization
Maximilian M. Sauer, M. Alejandra Tortorici, Young‐Jun Park, et al.
Nature Structural & Molecular Biology (2021) Vol. 28, Iss. 6, pp. 478-486
Open Access | Times Cited: 195

Showing 26-50 of 195 citing articles:

A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
Payton A. Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 56
Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines
Liyan Guo, Sheng Lin, Zimin Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 44
Proactive vaccination using multiviral Quartet Nanocages to elicit broad anti-coronavirus responses
Rory A. Hills, Tiong Kit Tan, Alexander A. Cohen, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 8, pp. 1216-1223
Open Access | Times Cited: 15
Molecular basis of convergent evolution of ACE2 receptor utilization among HKU5 coronaviruses
Young‐Jun Park, Chen Liu, Jimin Lee, et al.
Cell (2025)
Closed Access | Times Cited: 3
Current status of therapeutic monoclonal antibodies against SARS-CoV-2
Sanjeev Kumar, Anmol Chandele, Amit Sharma
PLoS Pathogens (2021) Vol. 17, Iss. 9, pp. e1009885-e1009885
Open Access | Times Cited: 97
Distant residues modulate conformational opening in SARS-CoV-2 spike protein
Dhiman Ray, Ly Le, Ioan Andricioaei
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 43
Open Access | Times Cited: 85
Stabilized coronavirus spike stem elicits a broadly protective antibody
Ching‐Lin Hsieh, Anne P. Werner, Sarah R. Leist, et al.
Cell Reports (2021) Vol. 37, Iss. 5, pp. 109929-109929
Open Access | Times Cited: 82
Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit
Nicholas K. Hurlburt, Leah J. Homad, Irika Sinha, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 66
Structure, receptor recognition, and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoprotein
M. Alejandra Tortorici, Alexandra C. Walls, Anshu Joshi, et al.
Cell (2022) Vol. 185, Iss. 13, pp. 2279-2291.e17
Open Access | Times Cited: 58
Challenges and developments in universal vaccine design against SARS-CoV-2 variants
Fangxin Zhao, Xiaodong Zai, Zhiling Zhang, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 56
A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
Wei Pang, Ying Lu, Yan‐Bo Zhao, et al.
Cell Research (2022) Vol. 32, Iss. 12, pp. 1068-1085
Open Access | Times Cited: 51
Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses
Cherrelle Dacon, Linghang Peng, Ting-Hui Lin, et al.
Cell Host & Microbe (2022) Vol. 31, Iss. 1, pp. 97-111.e12
Open Access | Times Cited: 39
Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination
Lily E. Adams, Sarah R. Leist, Kenneth H. Dinnon, et al.
Cell Reports (2023) Vol. 42, Iss. 4, pp. 112326-112326
Open Access | Times Cited: 35
SARS-CoV-2 spike S2-specific neutralizing antibodies
Chia‐Jung Li, Shih‐Chung Chang
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 33
Structure and inhibition of SARS-CoV-2 spike refolding in membranes
Michael W. Grunst, Zhuan Qin, Esteban Dodero‐Rojas, et al.
Science (2024) Vol. 385, Iss. 6710, pp. 757-765
Closed Access | Times Cited: 13
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
Ching‐Lin Hsieh, Sarah R. Leist, Emily Happy Miller, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans
Amin Addetia, Cameron Stewart, Albert J. Seo, et al.
Cell Reports (2024) Vol. 43, Iss. 8, pp. 114530-114530
Open Access | Times Cited: 8
Single-Molecule Investigation of the Binding Interface Stability of SARS-CoV-2 Variants with ACE2
Ankita Ray, Tran Thi Minh Thu, Rita dos Santos Natividade, et al.
ACS Nanoscience Au (2024) Vol. 4, Iss. 2, pp. 136-145
Open Access | Times Cited: 7
Molecular basis of immune evasion by the delta and kappa SARS-CoV-2 variants
Matthew McCallum, Alexandra C. Walls, Kaitlin R. Sprouse, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 52
Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers
Kanika Vanshylla, Chengcheng Fan, Marie Wunsch, et al.
Cell Host & Microbe (2021) Vol. 30, Iss. 1, pp. 69-82.e10
Open Access | Times Cited: 47
A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in mice
David R. Martinez, Alexandra Schaefer, S. Gobeil, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 43
Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses
Peter Halfmann, Steven J. Frey, Kathryn Loeffler, et al.
EBioMedicine (2022) Vol. 86, pp. 104341-104341
Open Access | Times Cited: 36
Glycosite-deleted mRNA of SARS-CoV-2 spike protein as a broad-spectrum vaccine
Chung‐Yi Wu, Cheng‐Wei Cheng, Chih‐Chuan Kung, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 9
Open Access | Times Cited: 35
Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: a serological analysis
Frauke Muecksch, Helen Wise, Kate Templeton, et al.
The Lancet Microbe (2022) Vol. 3, Iss. 7, pp. e493-e502
Open Access | Times Cited: 32
Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens
John C. Kraft, Minh N. Pham, Laila Shehata, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 10, pp. 100780-100780
Open Access | Times Cited: 31

Scroll to top